{"id":"https://openalex.org/W4362543545","doi":"https://doi.org/10.1158/1538-7445.am2023-1878","title":"Abstract 1878: Preclinical development of a novel bispecific mAb-Trap fusion protein, IMM2520, targeting both PD-L1 and CD47 as cancer immunotherapy","display_name":"Abstract 1878: Preclinical development of a novel bispecific mAb-Trap fusion protein, IMM2520, targeting both PD-L1 and CD47 as cancer immunotherapy","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362543545","doi":"https://doi.org/10.1158/1538-7445.am2023-1878"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-1878","doi":"https://doi.org/10.1158/1538-7445.am2023-1878","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-1878","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026718794","display_name":"Wenzhi Tian","orcid":"https://orcid.org/0000-0002-1986-4381","observed_orcids":["https://orcid.org/0000-0002-1986-4381","https://orcid.org/0009-0002-9733-0956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenzhi Tian","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100448223","display_name":"Song Li","orcid":"https://orcid.org/0000-0003-1658-949X","observed_orcids":["https://orcid.org/0000-0003-1658-949X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Song Li","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000096572","display_name":"Dianze Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dianze Chen","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100301546","display_name":"Wenqi Zhu","orcid":"https://orcid.org/0009-0008-0357-441X","observed_orcids":["https://orcid.org/0009-0008-0357-441X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenqi Zhu","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100636310","display_name":"Yanan Yang","orcid":"https://orcid.org/0000-0002-6326-9395","observed_orcids":["https://orcid.org/0000-0002-6326-9395"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanan Yang","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100327105","display_name":"Dandan Liu","orcid":"https://orcid.org/0000-0002-2090-9217","observed_orcids":["https://orcid.org/0000-0002-2090-9217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dandan Liu","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008079815","display_name":"Huiqin Guo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huiqin Guo","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045672922","display_name":"Chunmei Yang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chunmei Yang","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425554","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-3617-2627","observed_orcids":["https://orcid.org/0000-0002-3617-2627","https://orcid.org/0000-0003-2756-2620","https://orcid.org/0009-0001-8129-4308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100441688","display_name":"Wei Zhang","orcid":"https://orcid.org/0000-0002-6968-6974","observed_orcids":["https://orcid.org/0000-0002-6968-6974","https://orcid.org/0000-0001-5188-4772","https://orcid.org/0009-0005-6170-3695","https://orcid.org/0009-0009-9928-7315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Zhang","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036938112","display_name":"Xiaoping Tu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoping Tu","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005784828","display_name":"Liang Peng","orcid":"https://orcid.org/0009-0002-6792-602X","observed_orcids":["https://orcid.org/0009-0002-6792-602X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liang Peng","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019059122","display_name":"Gui Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gui Zhao","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008944253","display_name":"Ruliang Zhang","orcid":"https://orcid.org/0000-0003-1018-8134","observed_orcids":["https://orcid.org/0000-0003-1018-8134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruliang Zhang","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065523443","display_name":"Fan Zhang","orcid":"https://orcid.org/0000-0002-6102-2970","observed_orcids":["https://orcid.org/0000-0002-6102-2970"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fan Zhang","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066498219","display_name":"Frank X. Gan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank Gan","raw_affiliation_strings":["1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"1878","last_page":"1878"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.20759999752044678,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.7990000247955322},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cd47","display_name":"CD47","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sirpalpha","display_name":"SIRP\u03b1","score":0.9279999732971191},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7749999761581421},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.7699999809265137},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-phagocytosis","display_name":"antibody-dependent cellular phagocytosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.6600000262260437},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.503000020980835},{"id":"https://openalex.org/keywords/4t1-breast-cancer-model","display_name":"4T1 breast cancer","score":0.6800000071525574},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5550000071525574},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.5059999823570251},{"id":"https://openalex.org/keywords/preclinical-drug-development","display_name":"preclinical drug development","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C2780104668","wikidata":"https://www.wikidata.org/wiki/Q21108354","display_name":"CD47","level":3,"score":0.7439308762550354},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.6503206491470337},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5779117941856384},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.568656325340271},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5621535181999207},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5448193550109863},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.5201364159584045},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5116479992866516},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.49211806058883667},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4805086851119995},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.47817856073379517},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4506608545780182},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4405103921890259},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.41199684143066406},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37690553069114685},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33426064252853394},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29400211572647095},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2893207371234894},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10951828956604004},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.09506836533546448},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-1878","doi":"https://doi.org/10.1158/1538-7445.am2023-1878","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-1878","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403847937","https://openalex.org/W6922519929","https://openalex.org/W3202940562","https://openalex.org/W4310810230","https://openalex.org/W3099884836","https://openalex.org/W3211608945","https://openalex.org/W4402560081","https://openalex.org/W3212518782","https://openalex.org/W4308379195","https://openalex.org/W4362592403"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"programmed":[2,27],"cell":[3,33,146,176],"death":[4],"protein":[5,115],"1":[6,29,453],"(PD-1)":[7],"immune":[8,20,136,151],"checkpoint":[9,55,137],"is":[10,40,110,311],"well":[11,362],"known":[12],"in":[13,22,36,101,107,214,328,343],"its":[14,25,356],"ability":[15],"to":[16,130,141,177,195,313,352],"attenuate":[17],"T":[18,154],"cell-mediated":[19],"responses":[21],"tumors":[23],"expressing":[24],"ligand,":[26],"death-ligand":[28],"(PD-L1).":[30],"CD47,":[31],"a":[32,94,191,211,227,241,283,299,339,344,372,424],"surface":[34],"molecule":[35],"the":[37,58,74,102,144,150,159,169,174,303,323,364,443],"immunoglobulin":[38],"superfamily,":[39],"another":[41,327],"established":[42,324],"target":[43],"overexpressed":[44],"on":[45,77,143,165,173,179,384],"various":[46],"malignant":[47],"cells":[48,62,89,164],"and":[49,63,80,86,121,128,134,148,201,239,285,296,382,434,455],"acts":[50],"as":[51,361,363,371,436],"an":[52,111],"innate":[53,67,133],"inhibitory":[54,160],"by":[56,167,379],"interrupting":[57],"phagocytosis":[59,245],"of":[60,66,117,153,162,171,307,318,423,442],"tumor":[61,84,88,104,145,163,175,272,385],"downstream":[64],"activation":[65],"responses.":[68],"It":[69],"has":[70],"been":[71],"reported":[72],"that":[73,186,265],"simultaneous":[75],"blockade":[76],"both":[78,132,432],"CD47":[79,127,172,196,383,435],"PD-L1":[81,123,129,142,202,309,381,433],"checkpoints":[82],"inhibited":[83],"growth":[85],"circulating":[87],"metastasis":[90],"more":[91],"potently":[92],"than":[93,290],"single":[95],"antibody":[96,310],"inhibition":[97],"or":[98],"blank":[99],"control":[100],"4T1":[103],"mouse":[105],"model":[106,263],"vivo.":[108],"IMM2520":[109,139,156,187,224,266,281,315,337,368],"antibody-receptor":[112],"(mAb-Trap)":[113],"fusion":[114,294,428],"consisting":[116],"recombinant":[118],"human":[119],"SIRP\u03b1":[120,178],"anti-":[122],"antibody,":[124],"thereby":[125],"targeting":[126,380,431],"antagonize":[131],"adaptive":[135],"pathways.":[138],"binds":[140],"membrane":[147],"restores":[149],"response":[152],"cells.":[155,386],"also":[157,209,225],"reverses":[158],"effect":[161],"macrophages":[166],"blocking":[168,215],"binding":[170,193,217],"macrophages.":[180],"In":[181,255,326],"vitro":[182],"studies":[183],"have":[184],"demonstrated":[185,264,282,338],"not":[188],"only":[189],"possesses":[190],"potent":[192,228,284,357,373],"activity":[194,213,251,342,360],"(EC50":[197,203],"=":[198,204,219,234,248,275],"0.8":[199],"nM)":[200,206,250],"0.09":[205],"respectively,":[207],"but":[208,302],"exhibits":[210],"strong":[212,242],"PD-1/PD-L1":[216],"(IC50":[218],"0.06":[220],"-":[221],"1.0":[222],"nM).":[223],"showed":[226],"antibody-dependent":[229,243],"cellular":[230,244],"cytotoxicity":[231],"(ADCC,":[232],"EC50":[233,247],"1.54":[235],"ng/ml)":[236],"against":[237,253],"Raji-PDL1":[238],"induced":[240],"(ADCP,":[246],"0.04":[249],"(THP-1":[252],"Raji-PDL1).":[254],"vivo":[256,329],"efficacy":[257,330],"study":[258,331],"with":[259,332],"CT26-hPD-L1/hCD47":[260],"colon":[261,334],"cancer":[262,335,377,437],"at":[267,316,347],"3":[268],"mg/kg":[269,320,351],"significantly":[270,286],"reduced":[271],"volume":[273],"(TGITV":[274],"90.12%,":[276],"P<0.01":[277],"vs":[278],"Vehicle).":[279],"Interestingly,":[280],"higher":[287],"anti-tumor":[288,341,359],"activities":[289],"IMM01":[291],"(a":[292],"SIRP\u03b1-Fc":[293],"protein)":[295],"IMM2505":[297],"(also":[298],"CD47XPD-L1":[300],"mAb-Trap,":[301],"variable":[304],"region":[305],"sequence":[306],"this":[308],"identical":[312],"atezolizumab).":[314],"dose":[317],"6":[319],"completely":[321],"eradicated":[322],"tumors.":[325],"MC38-hCD47/hPD-L1":[333],"model,":[336],"significant":[340],"dose-dependent":[345],"manner":[346],"doses":[348],"between":[349],"2":[350],"20":[353],"mg/kg.":[354],"Given":[355],"preclinical":[358],"favorable":[365],"safety":[366],"profile,":[367],"may":[369],"serve":[370],"immunotherapy":[374,438],"for":[375,446],"multiple":[376],"types":[378],"Citation":[387],"Format:":[388],"Wenzhi":[389],"Tian,":[390],"Song":[391],"Li,":[392],"Dianze":[393],"Chen,":[394],"Wenqi":[395],"Zhu,":[396],"Yanan":[397],"Yang,":[398,404],"Dandan":[399],"Liu,":[400],"Huiqin":[401],"Guo,":[402],"Chunmei":[403],"Li":[405],"Zhang,":[406,408,416,418],"Wei":[407],"Xiaoping":[409],"Tu,":[410],"Liang":[411],"Peng,":[412],"Gui":[413],"Zhao,":[414],"Ruliang":[415],"Fan":[417],"Frank":[419],"Gan.":[420],"Preclinical":[421],"development":[422],"novel":[425],"bispecific":[426],"mAb-Trap":[427],"protein,":[429],"IMM2520,":[430],"[abstract].":[439],"In:":[440],"Proceedings":[441],"American":[444],"Association":[445],"Cancer":[447,466],"Research":[448],"Annual":[449],"Meeting":[450],"2023;":[451],"Part":[452],"(Regular":[454],"Invited":[456],"Abstracts);":[457],"2023":[458],"Apr":[459],"14-19;":[460],"Orlando,":[461],"FL.":[462],"Philadelphia":[463],"(PA):":[464],"AACR;":[465],"Res":[467],"2023;83(7_Suppl):Abstract":[468],"nr":[469],"1878.":[470]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-04-06T00:00:00"}